Searched for
CORONARY DRUG ELUTING STENT MARKET
Don't stunt the stent, med devices sectorThree coronary stent models from Meril Life Sciences were withdrawn from the Sri Lankan market due to performance issues. The National Medi...- NATCO Pharma subsidiary launches Carboplatin in US market to address shortagesIndian pharmaceutical company NATCO Pharma annouced the launch of Carboplatin Injection, a generic version of Paraplatin in the US market b...
- Sahajanand Medical Technologies IPO Day 3: GMP at 7%; check subscription status and key detailsSahajanand Medical Technologies’ IPO enters its final bidding day with 82% subscription on Day 2 and a 7% grey market premium. The Rs 475.4...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- Akal Takht Jathedar Gargajj accords Parvinder Singh Jhota as martyr of Sikh communityAkal Takht Jathedar Giani Kuldip Singh Gargajj conferred the status of a martyr of the Sikh community to Parvinder Singh Jhota. The develop...
- Sahajanand Medical Technologies IPO Day 2: Check GMP, subscription status and key detailsSahajanand Medical Technologies IPO entered Day 2 on October 16, 2026, with a 12% GMP and 34% subscription on Day 1. The Rs 475.48-crore of...
- Sahajanand Medical Technologies IPO opens for subscription. Check GMP, price band and key detailsSahajanand Medical Technologies IPO opened for subscription on October 15, 2026, aiming to raise Rs 475.48 crore through an entirely offer-...
- Health ministry asked to examine coronary stent safety concernsCabinet secretariat has directed the Union health ministry to investigate safety issues related to coronary stents. These concerns were rai...
- Delhi CM Rekha Gupta says CJP acting like AAP's B-Team, dares it to protest in PunjabDelhi Chief Minister Rekha Gupta accused the Cockroach Janta Party (CJP) of acting like the Aam Admi Party's (AAP) "B-team" and accused it ...
- Anti-drug activist Parvinder Singh shot dead by medical store owner in Punjab's MansaParvinder Singh, an anti-drug activist, was shot dead in Mansa, Punjab, after confronting a pharmacy owner. Tensions escalated as Singh's s...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growthKiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need f...
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- SC asks govt to broaden inflated pricing review beyond oncologyThe Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...
- Supreme Court questions govt over drug pricing, asks why cap limited to anti-cancer medicinesThe Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...
- Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...
- NCB seizes 53.9 kg methamphetamine worth Rs 43 crore in GuwahatiThe Narcotics Control Bureau in Guwahati carried out an operation resulting in a significant drug seizure. Officers intercepted two trucks ...
- IPO calendar: After a week of lull, 5 companies to raise nearly Rs 1,600 crore this weekFive IPOs are scheduled to open for subscription next week, including mainboard issues from HD Fire Protect, Fusion CX and Sahajanand Medic...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
Load More
